HRL
38
2
DNB
32
8
LOW
56
3
LUV
52
4
COST
66
5
APD
44
4
UA
33
4
ADI
61
4
A
44
-2
BAC
48
10
HUM
40
4
TSCO
50
-6
CNX
63
2
SYF
95
3
SLG
62
6
ESS
70
2
PHM
71
2
M
48
6
WMB
64
2
HAS
51
2
HRL
38
2
DNB
32
8
LOW
56
3
LUV
52
4
COST
66
5
APD
44
4
UA
33
4
ADI
61
4
A
44
-2
BAC
48
10
HUM
40
4
TSCO
50
-6
CNX
63
2
SYF
95
3
SLG
62
6
ESS
70
2
PHM
71
2
M
48
6
WMB
64
2
HAS
51
2
Financhill
Back

PTC Therapeutics 10K Form

Buy
66

PTCT
PTC Therapeutics

Last Price:
33.40
Seasonality Move:
12.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-10-26 10Q PTCT/PTC Therapeutics Quarterly
2023-08-03 10Q PTCT/PTC Therapeutics Quarterly
2023-04-27 10Q PTCT/PTC Therapeutics Quarterly
2022-10-27 10Q PTCT/PTC Therapeutics Quarterly
2022-08-04 10Q PTCT/PTC Therapeutics Quarterly
2022-05-03 10Q PTCT/PTC Therapeutics Quarterly

Receive PTCT News And Ratings

See the #1 stock for the next 7 days that we like better than PTCT

PTCT Financial Statistics

Sales & Book Value

Annual Sales: $937.82M
Cash Flow: $6.41M
Price / Cash Flow: 0
Annual Sales: $-11.66
Price / Book: 0

Profitability

EPS (TTM): -7.68000
Net Income (TTM): $-579.22M
Gross Margin: $872.34M
Return on Equity: 0%
Return on Assets: -36.7%

PTC Therapeutics Earnings Forecast

Key PTC Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 11 years for PTCT is 93.02%.
  • The Selling, General & Administrative Expenses for PTCT have been equal to 35.46% of Gross Profit Margin.
  • The Research & Development expenses have been 71.08% of Revenue.
  • The Interest Expense is -20.62% of Operating Income.
  • The Net Earning history of PTCT is -66.81% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 4 years.

PTC Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PTCT
CUSIP: 69366J
Website: ptcbio.com

Debt

Debt-to-Equity Ratio: -0.32
Current Ratio: 2.03
Quick Ratio: 1.88

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PTCT Technical Analysis vs Fundamental Analysis

Buy
66
PTC Therapeutics (PTCT) is a Buy

Is PTC Therapeutics a Buy or a Sell?

  • PTC Therapeutics stock is rated a Buy
    The current PTC Therapeutics [PTCT] share price is $33.62. The Score for PTCT is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.